Trial
NCT03891264
Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
—
Condition
Back Pain, Low
Intervention
Cannabidiol
Why stopped
Funding obtained to do a larger placebo-controlled trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-05-04